Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Regulatory FDF Prices
NA
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. Disulfide, Thiamine Tetrahydrofurfuryl
2. Fursultiamin
3. Fursultiamin Hydrochloride
4. Fursultiamin Monohydrochloride
5. Hydrochloride, Fursultiamin
6. Monohydrochloride, Fursultiamin
7. Thiamine Tetrahydrofurfuryl Disulfide
1. 804-30-8
2. Fursultiamin
3. Alinamin F
4. Ttfd
5. Thiamine Tetrahydrofurfuryl Disulfide
6. Thiamin Tetrahydrofurfuryl Disulfide
7. Diteftin
8. Alinamin-f
9. Aliaron F
10. Judolor
11. Fursultiamine Hydrochloride
12. Linamin
13. 05j61265px
14. Formamide, N-((4-amino-2-methyl-5-pyrimidinyl)methyl)-n-(4-hydroxy-1-methyl-2-(((tetrahydro-2-furanyl)methyl)dithio)-1-butenyl)-
15. N-[(4-amino-2-methylpyrimidin-5-yl)methyl]-n-[(e)-5-hydroxy-3-(oxolan-2-ylmethyldisulfanyl)pent-2-en-2-yl]formamide
16. (e)-n-((4-amino-2-methylpyrimidin-5-yl)methyl)-n-(5-hydroxy-3-(((tetrahydrofuran-2-yl)methyl)disulfanyl)pent-2-en-2-yl)formamide
17. N-((4-amino-2-methyl-5-pyrimidinyl)methyl)-n-(4-hydroxy-1-methyl-2-((tetrahydrofurfuryl)dithio)-1-butenyl)formamide
18. Retar B1
19. Retar-b(sub 1)
20. Fursultiamina
21. Fursultiaminum
22. Fursultiamine [inn:jan]
23. Tetrahydrofurfuryl Thiamine Disulfide
24. Fursultiaminum [inn-latin]
25. Fursultiamina [inn-spanish]
26. Formamide, N-[(4-amino-2-methyl-5-pyrimidinyl)methyl]-n-[4-hydroxy-1-methyl-2-[[(tetrahydro-2-furanyl)methyl]dithio]-1-butenyl]-
27. N-((4-amino-2-methylpyrimidin-5-yl)methyl)-n-(5-hydroxy-3-(((tetrahydrofuran-2-yl)methyl)disulfanyl)pent-2-en-2-yl)formamide
28. Einecs 212-357-1
29. Brn 0052964
30. Fursutiamine
31. Unii-05j61265px
32. Ncgc00188432-01
33. N-((4-amino-2-methylpyrimidin-5-yl)methyl)-n-((1e)-4-hydroxy-1-methyl-2-((tetrahydrofuran-2-ylmethyl)disulfanyl)but-1-en-1-yl)formamide
34. N-[(4-amino-2-methylpyrimidin-5-yl)methyl]-n-{(1e)-4-hydroxy-1-methyl-2-[(tetrahydrofuran-2-ylmethyl)disulfanyl]but-1-en-1-yl}formamide
35. Prestwick2_001007
36. Prestwick3_001007
37. Dsstox_cid_3084
38. Fursultiamine [mi]
39. Fursultiamine [inn]
40. Fursultiamine [jan]
41. Dsstox_rid_76867
42. Dsstox_gsid_23084
43. Schembl24002
44. Schembl24003
45. Bspbio_001133
46. 5-25-12-00167 (beilstein Handbook Reference)
47. Mls006010098
48. Fursultiamine [mart.]
49. Fursultiamine [who-dd]
50. Bpbio1_001247
51. Chembl1740659
52. Chebi:91836
53. Chebi:135636
54. Hy-b2082
55. Tox21_112989
56. Mfcd00867383
57. Akos015961066
58. Ac-4505
59. Cs-8111
60. Db08966
61. Ncgc00179291-01
62. Ncgc00179291-04
63. 10238-39-8
64. As-14765
65. Cas-804-30-8
66. Formamide, N-((4-amino-2-methyl-5-pyrimidinyl)methyl)-n-(4-hydroxy-1-methyl-2-((tetrahydrofurfuryl)dithio)-1-butenyl)-
67. N-[(4-amino-2-methyl-pyrimidin-5-yl)methyl]-n-[(e)-4-hydroxy-1-methyl-2-(tetrahydrofuran-2-ylmethyldisulfanyl)but-1-enyl]formamide
68. Smr001827667
69. Ab00443520
70. S6614
71. 804f308
72. A839907
73. Q-201140
74. Q5509734
75. Brd-a71157293-003-03-5
76. N-[(4-amino-2-methyl-5-pyrimidinyl)methyl]-n-[(e)-5-hydroxy-3-(2-oxolanylmethyldisulfanyl)pent-2-en-2-yl]formamide
77. N-[(4-amino-2-methylpyrimidin-5-yl)methyl]-n-[5-hydroxy-3-(oxolan-2-ylmethyldisulfanyl)pent-2-en-2-yl]formamide
78. N-[(4-azanyl-2-methyl-pyrimidin-5-yl)methyl]-n-[(e)-5-oxidanyl-3-(oxolan-2-ylmethyldisulfanyl)pent-2-en-2-yl]methanamide
Molecular Weight | 398.5 g/mol |
---|---|
Molecular Formula | C17H26N4O3S2 |
XLogP3 | 0.6 |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 8 |
Rotatable Bond Count | 9 |
Exact Mass | 398.14463305 g/mol |
Monoisotopic Mass | 398.14463305 g/mol |
Topological Polar Surface Area | 152 Ų |
Heavy Atom Count | 26 |
Formal Charge | 0 |
Complexity | 481 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 1 |
Defined Bond Stereocenter Count | 1 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Vitamin B Complex
A group of water-soluble vitamins, some of which are COENZYMES. (See all compounds classified as Vitamin B Complex.)
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
16
PharmaCompass offers a list of Fursultiamine API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Fursultiamine manufacturer or Fursultiamine supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Fursultiamine manufacturer or Fursultiamine supplier.
PharmaCompass also assists you with knowing the Fursultiamine API Price utilized in the formulation of products. Fursultiamine API Price is not always fixed or binding as the Fursultiamine Price is obtained through a variety of data sources. The Fursultiamine Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A TTFD manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of TTFD, including repackagers and relabelers. The FDA regulates TTFD manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. TTFD API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of TTFD manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A TTFD supplier is an individual or a company that provides TTFD active pharmaceutical ingredient (API) or TTFD finished formulations upon request. The TTFD suppliers may include TTFD API manufacturers, exporters, distributors and traders.
click here to find a list of TTFD suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The TTFD Drug Master File in Japan (TTFD JDMF) empowers TTFD API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the TTFD JDMF during the approval evaluation for pharmaceutical products. At the time of TTFD JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of TTFD suppliers with JDMF on PharmaCompass.
TTFD Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of TTFD GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right TTFD GMP manufacturer or TTFD GMP API supplier for your needs.
A TTFD CoA (Certificate of Analysis) is a formal document that attests to TTFD's compliance with TTFD specifications and serves as a tool for batch-level quality control.
TTFD CoA mostly includes findings from lab analyses of a specific batch. For each TTFD CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
TTFD may be tested according to a variety of international standards, such as European Pharmacopoeia (TTFD EP), TTFD JP (Japanese Pharmacopeia) and the US Pharmacopoeia (TTFD USP).